Home
BENLYSTA

BENLYSTA Market Share Analysis for May 2026

Learn more about taking BENLYSTA (belimumab). Talk to your doctor for more information about BENLYSTA.

Health > Pharmacy

Domainbenlysta.com

Year Founded--

Employees51 - 200

Annual Revenue$15M - $25M

BENLYSTA

BENLYSTA (including company regionals)

benlysta.com

See more website traffic and engagement information

BENLYSTA Revenue up to May 2026 is 15M - 25M

revenue generated by BENLYSTA top domains

BENLYSTA top domains revenue over 3 years

Revenue for BENLYSTA top domains

benlysta.com15M - 25M

See more with Sales Intelligence

Total visits to BENLYSTA's top domains

Understand BENLYSTA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

benlysta.com121.4K

See more with Sales Intelligence

Avg. visit duration in BENLYSTA's top domains

Analyze BENLYSTA engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

benlysta.com00:01:35

See more with Sales Intelligence

Avg. pageviews on BENLYSTA's top domains

See how BENLYSTA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

benlysta.com1.90

See more with Sales Intelligence

BENLYSTA top competitors by domain

Top similar sites in May 2026, ranked by their affinity

lupus.orgCompany NameLupus Foundation of AmericaEmployees51 - 200HQUnited States, District of Columbia, Washington, D.C.Annual revenue$15M - $25MTotal visits304.7KHealth > Health Conditions and Concerns

Top technologies used by BENLYSTA

These are the website technologies, by industry, used by BENLYSTA top domains

Advertising (19)

DoubleClick

Conversion & Analytics (10)

Google Analytics

Widget (6)

Google Maps

Marketing (5)

Google Marketing Platform

More Technologies

8

See all

News & Signals from BENLYSTA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAstraZeneca plc identified as competitor of Benlysta.The regulatory decision gives AstraZeneca a product that can compete head-to-head with GlaxoSmithKline’s lupus drug, Benlysta.